Recombinant yeast screen for new inhibitors of human acetyl-CoA carboxylase 2 identifies potential drugs to treat obesity.
about
A novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosisStructure and function of biotin-dependent carboxylasesYeast toxicogenomics: genome-wide responses to chemical stresses with impact in environmental health, pharmacology, and biotechnologyFunctional expression of parasite drug targets and their human orthologs in yeastIdentification of an aminothiazole with antifungal activity against intracellular Histoplasma capsulatum.Screen for small molecules increasing the mitochondrial membrane potential.The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase.Yeast-based automated high-throughput screens to identify anti-parasitic lead compoundsTargeting the latest hallmark of cancer: another attempt at 'magic bullet' drugs targeting cancers' metabolic phenotype.The utility of yeast as a tool for cell-based, target-directed high-throughput screening.Yeast as a potential vehicle for neglected tropical disease drug discovery.Analysis of Arabidopsis Accessions Hypersensitive to a Loss of Chloroplast Translation.Genetic engineering and molecular characterization of yeast strain expressing hybrid human-yeast squalene synthase as a tool for anti-cholesterol drug assessment.Yeast as a tool to identify anti-aging compounds.
P2860
Q26774351-7B61F4AE-5FAA-4D33-BC6A-BD03EF274447Q26851762-6A8671DC-15D7-4477-9BED-39946F35B671Q28383634-36F084A2-F9C9-4BEB-B04F-079E29372DC3Q28477338-E0D0570C-DB7A-4B56-9E1E-87E2EA3171C8Q34788828-42029381-80B8-4A78-8A95-02A0B53CE131Q34836339-A2009DB1-291F-4E96-9899-F5837A2ECD28Q35017735-30A6ECA2-0DCF-454A-AD54-3185EB9ADF4CQ36702409-69F08C8B-1FFD-4F8C-BFC1-B8E7411B004BQ38058130-368B3B1F-571F-488E-A2DA-2E65E74F6753Q38101070-FD4A6626-00E4-4E11-8EF3-0B1737F992A4Q38239749-FE1E45AE-06DD-42DA-B8FE-2A63A6CFCBD5Q38809395-53BBA4D6-0579-44A9-8D97-0A9A22DC6699Q51565685-EBC5521D-6A1B-47BD-9632-A2258ECCD8E1Q55262989-0FE5CF1F-8692-48D0-BCC4-3D1E80F08DDD
P2860
Recombinant yeast screen for new inhibitors of human acetyl-CoA carboxylase 2 identifies potential drugs to treat obesity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Recombinant yeast screen for n ...... ential drugs to treat obesity.
@ast
Recombinant yeast screen for n ...... ential drugs to treat obesity.
@en
Recombinant yeast screen for n ...... ential drugs to treat obesity.
@nl
type
label
Recombinant yeast screen for n ...... ential drugs to treat obesity.
@ast
Recombinant yeast screen for n ...... ential drugs to treat obesity.
@en
Recombinant yeast screen for n ...... ential drugs to treat obesity.
@nl
prefLabel
Recombinant yeast screen for n ...... ential drugs to treat obesity.
@ast
Recombinant yeast screen for n ...... ential drugs to treat obesity.
@en
Recombinant yeast screen for n ...... ential drugs to treat obesity.
@nl
P2093
P2860
P356
P1476
Recombinant yeast screen for n ...... ential drugs to treat obesity.
@en
P2093
Adam Coster
Caroline Patenode
Dominika Chalupska
Evan Arnold
George Anesi
Jasmina Marjanovic
Piotr Gornicki
Robert Haselkorn
P2860
P304
P356
10.1073/PNAS.1003721107
P407
P577
2010-05-03T00:00:00Z